LCM
Laurion Capital Management’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-7,939
| Closed | -$932K | – | 356 |
|
|
2022
Q1 | $932K | Buy |
+7,939
| New | +$932K | 0.01% | 146 |
|
|
2021
Q3 | – | Sell |
-20,699
| Closed | -$2.72M | – | 437 |
|
|
2021
Q2 | $2.72M | Buy |
+20,699
| New | +$2.72M | 0.02% | 145 |
|
|
2020
Q4 | – | Sell |
-6,500
| Closed | -$1M | – | 429 |
|
|
2020
Q3 | $1M | Sell |
6,500
-190
| -3% | -$29.3K | 0.01% | 281 |
|
|
2020
Q2 | $989K | Buy |
+6,690
| New | +$989K | 0.01% | 253 |
|
|
2020
Q1 | – | Sell |
-9,100
| Closed | -$1.27M | – | 464 |
|
|
2019
Q4 | $1.27M | Buy |
9,100
+5,078
| +126% | +$706K | 0.01% | 198 |
|
|
2019
Q3 | $387K | Sell |
4,022
-12,210
| -75% | -$1.17M | ﹤0.01% | 429 |
|
|
2019
Q2 | $1.87M | Buy |
+16,232
| New | +$1.87M | 0.02% | 144 |
|
|
2018
Q1 | – | Sell |
-54,952
| Closed | -$2.2M | – | 1025 |
|
|
2017
Q4 | $2.2M | Sell |
54,952
-228,378
| -81% | -$9.15M | 0.01% | 390 |
|
|
2017
Q3 | $10.3M | Buy |
+283,330
| New | +$10.3M | 0.05% | 91 |
|
|
2017
Q1 | – | Sell |
-83,200
| Closed | -$1.68M | – | 823 |
|
|
2016
Q4 | $1.68M | Buy |
+83,200
| New | +$1.68M | 0.02% | 256 |
|